Clinical trial

Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement…

NCT00264368 · University of Oslo School of Pharmacy, Other · Terminated

Key facts

NCT number NCT00264368
Title Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Official title Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Lead sponsor University of Oslo School of Pharmacy, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Acute Renal Failure, Cytomegalovirus Infections, Multi Organ Failure
Intervention type Drug
Interventions intravenous (IV) ganciclovir
Enrollment 6
Start date Dec 1, 2005
Completion Jun 1, 2007
First posted Dec 12, 2005
Last update posted Jun 28, 2007
Countries Norway

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies